@bells this is in the strategic plan. You'll see meshes mentioned multiple times in early presentations, it's not however prudent to chase that market now with the resources we have, before the cardiac market has been bedded in. Wayne has plenty to do there and once CF+ comes he will then look at this type of expansion. My guess would be at least 5yrs away.
The good news is that imho once market credibility and dominance is achieved in cardiac uses it will be a no-brainer for surgeons to use Adapt mesh for hernia/vaginal/abdo repairs. The roll out will be much faster I should think.
@bells this is in the strategic plan. You'll see meshes...
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.91 | 475 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |